Naoto T. Ueno, Director at University of Hawaii Cancer Center, shared a post on X, about a recent paper published in JCO Precision Oncology:
Authors: Christos Vaklavas, Cindy B. Matsen, Zhengtao Chu, Kenneth M. Boucher, Sandra D. Scherer, Satya Pathi, Anna Beck, Kirstyn E. Brownson, Saundra S. Buys, Namita Chittoria, Elyse D’Astous, H. Evin Gulbahce, N. Lynn Henry, Stephen Kimani, Jane Porretta, Regina Rosenthal, John Ward, Mei Wei, Bryan E. Welm, Alana L. Welm.
”A fascinating result is that engraftment to develop PDX predicts the response to systemic treatment in patients with triple-negative breast cancer. This is an article by a great cancer biologist, Alana Welm.”
Source: Naoto T. Ueno/X